These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 5401724)

  • 1. [Preliminary report on the results of retreatment with rifomycin AMP and ethambutol].
    Ibarra JP; Costa de Mello B; Mazza de Pratto N
    Hoja Tisiol; 1969; 26(1):113-26. PubMed ID: 5401724
    [No Abstract]   [Full Text] [Related]  

  • 2. [Retreatment of tuberculosis resistent to 1st and 2d line drugs with AMP rifomycin and ethambutol].
    Ibarra JP; Pińeyro J; Mello Aguerre M; Pintos Fuentes R; Trenchi A; Freijeiro R; Bazerque E
    Hoja Tisiol; 1970; 27(1):98-117. PubMed ID: 5524669
    [No Abstract]   [Full Text] [Related]  

  • 3. [3 cases of treatment of advanced tuberculosis with multiresistant bacilli by combined rifomycin-ethambutol].
    Hennebert A
    Acta Tuberc Pneumol Belg; 1969; 60(3):507-12. PubMed ID: 5371675
    [No Abstract]   [Full Text] [Related]  

  • 4. [Initial provisional record of treatment of relapses of active pulmonary tuberculosis with combined rifomycin, ethambutol and thiocarlide].
    Favez G; Willa C
    Acta Tuberc Pneumol Belg; 1969; 60(3):496-500. PubMed ID: 5392721
    [No Abstract]   [Full Text] [Related]  

  • 5. [Progress in the treatment of tuberculosis. Isoniazid plus rifomycin plus myambutol equals standard therapy].
    Freerksen E
    Dtsch Med Wochenschr; 1970 Jan; 95(3):139-41. PubMed ID: 5411222
    [No Abstract]   [Full Text] [Related]  

  • 6. [Chemotherapeutic effect and pharmacokinetics of rifampicin and ethambutol].
    Drabkina RO; Ginzburg TS
    Probl Tuberk; 1975; (3):69-74. PubMed ID: 1135208
    [No Abstract]   [Full Text] [Related]  

  • 7. Rifampin and ethambutol in the retreatment of advanced pulmonary tuberculosis.
    Gyselen A; Verbist L; Cosemans J; Lacquet LM; Vandenbergh E
    Am Rev Respir Dis; 1968 Dec; 98(6):933-41. PubMed ID: 4301381
    [No Abstract]   [Full Text] [Related]  

  • 8. [Intermittent treatment of "intractable chronic tuberculosis" by combined rifampicin-ethambutol: preliminary results of a controlled survey made in Algeria].
    Larbaoui D; Chaulet P; Grosset J; Abderrahim K; Oussedik N; Coucke C; Benabdallah L
    Rev Tuberc Pneumol (Paris); 1970 Jun; 34(4):559-66. PubMed ID: 4928583
    [No Abstract]   [Full Text] [Related]  

  • 9. First experience with rifampicin in retreatment of resistant cases.
    Tousek J
    Acta Tuberc Pneumol Belg; 1969; 60(3):478-81. PubMed ID: 5371672
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of chronic destructive pulmonary tuberculosis with rifampicin and ethambutol].
    Shmelev NA; Korotaev GA; Kaminskaia AA
    Probl Tuberk; 1971; 49(7):21-4. PubMed ID: 5146090
    [No Abstract]   [Full Text] [Related]  

  • 11. Combined treatment with rifampicin-ethambutol-capreomycin in chronic open pulmonary tuberculosis.
    Virchow C; Flemming J
    Acta Tuberc Pneumol Belg; 1969; 60(3):466-70. PubMed ID: 5371671
    [No Abstract]   [Full Text] [Related]  

  • 12. Rifampicin--ethambutol in retreatment of pulmonary tuberculosis.
    Mital OP; Narang RK; Sachan AS
    Indian J Chest Dis Allied Sci; 1976 Jul; 18(3):141-5. PubMed ID: 1026643
    [No Abstract]   [Full Text] [Related]  

  • 13. [Results of initial treatment of pulmonary tuberculosis using ethambutol, isonicotinic acid hydrazide and rifampicin].
    Kesztele V; Niederkofler J
    Wien Med Wochenschr; 1970 Jun; 120(25):473-5. PubMed ID: 5518004
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of intractable pulmonary tuberculosis: place of capreomycin in therapeutic programs with rifampicin and ethambutol].
    Oury M; Tuchais E; Norval C; Carbonnelle B; Leroux MF; Corre C; Parvery F
    Rev Tuberc Pneumol (Paris); 1970 Jun; 34(4):519-30. PubMed ID: 5510321
    [No Abstract]   [Full Text] [Related]  

  • 15. [Place of ethambutol associated with isoniazid or with rifampicin in the treatment of pulmonary tuberculosis].
    Lesobre R; Frey N
    Therapeutique; 1971 Apr; 47(4):387-90. PubMed ID: 5564051
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experience with te new antitubercular agents isoxyl, ethambutol, morphazinamid and rifomycin].
    Daddi G
    Wien Med Wochenschr; 1967 Mar; 117(11):266-8. PubMed ID: 5626324
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of ethambutol in the treatment of pulmonary tuberculosis].
    Ershov AI; Grigaliunas AP; Vasil'eva IR; Zolotareva NI; Dul'tseva EG
    Probl Tuberk; 1973; 51(12):33-6. PubMed ID: 4782100
    [No Abstract]   [Full Text] [Related]  

  • 18. [Rifampicin; its value and its limitations in tuberculosis, chronic or of severe onset, with or without associated ethambutol].
    Tricoire J; Marécaux L
    Rev Tuberc Pneumol (Paris); 1969 Mar; 33(2):226-41. PubMed ID: 5385585
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of chronic tuberculosis patients with ethambutol and protoionamide combined with rifampicin and capreomicin].
    Grassi C; Cornia G; Cirianni C; Garimoldi M; Ginesu F; Mandler F; Perna G; Pradella F
    G Ital Chemioter; 1968; 15(4):92-4. PubMed ID: 5744843
    [No Abstract]   [Full Text] [Related]  

  • 20. Rifampicin-ethambutol in the treatment of resistant pulmonary tuberculosis.
    Hertrick C; Ras R; Turri M
    Ger Med Mon; 1971; 1(1):34-7. PubMed ID: 5579591
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.